Diabetes Awareness Month: Top diabetic retinopathy items in ophthalmology

Catch up on Healio’s news in diabetic retinopathy for Diabetes Awareness Month.

Topics include AI screening software, benefits of teleretinal screening and study results.

Q&A: AI software offers cost-effective DR screening without internet access

Divya Rao, MS, chief medical officer of Remidio, spoke with Healio about how Medios DR AI allows for more affordable and accessible diabetic retinopathy screening. Read more.

Teleretinal screening for diabetic retinopathy beneficial

Teleretinal screening for diabetic retinopathy has several benefits, including increased capacity and better compliance. Read more.

VIDEO: OTX-TKI for NPDR shows promising safety, tolerability at 48 weeks

Dilsher Dhoot, MD, of California Retina Consultants discusses interim safety and efficacy results for OTX-TKI for the treatment of nonproliferative diabetic retinopathy. Watch here.

APX3330 oral treatment for diabetic retinopathy shows encouraging phase 2 data

APX3330, an investigational systemic treatment for diabetic retinopathy, showed encouraging outcomes in the phase 2 ZETA-1 trial, paving the way to phase 3. Read more.

VIDEO: Port delivery system maintains improvements in diabetic retinopathy at 2 years

Margaret Chang, MD, MS, of Retinal Consultants Medical Group presents 2-year results for the port delivery system with ranibizumab. Watch here.

Published by:

Read more about

This post was originally published on this site